SG · Sweetgreen, Inc. · Stock research

• # SG — Sweetgreen, Inc.

Current Thesis

The narrative an investor was buying in June and July — an exogenous, one-quarter food-safety dent sitting on top of a self-help margin recovery — was withdrawn by the company that issued it on 2026-08-06. FY26 comparable sales went to −8.0%/−7.0% from −4%/−2%, restaurant-level margin to 10.5–11.0% from 14.2–14.7%, and adjusted EBITDA to a loss of $23–27M from a guided $1–6M profit. Eight desks reset targets into a $5.00–$8.50 band over the following week.

What has happened since the last update is price, not information. The shares closed at $6.99 on 2026-08-21, a gain of 6.23% on the day from a $6.58 prior close (stockanalysis.com quote data as of 2026-08-22), against a 2026-08-14 close of $6.28. The only dated company items in that window are a fourth Sweetlane drive-thru opening in McLean, Virginia on 2026-08-20 and a limited-edition Fishwife tinned-fish Niçoise salad on 2026-08-11. Neither carries a P&L number. The inference: an approximately 24.5%-shorted float is drifting higher in a catalyst vacuum, with no company-scheduled event before the Q3 print in early November.

The narrative is dead. The turnaround narrative was retracted by management on 2026-08-06 and priced out by brokers on 2026-08-07 and 2026-08-10. What trades now is positioning mechanics on a $832.10M market cap (119.04M shares outstanding, stockanalysis.com as of 2026-08-22), and positioning is not a story that compounds — it resolves.

Bullish and bearish views on Sweetgreen, Inc.

The model's bull view on Sweetgreen, Inc. (SG), in brief: The guide-down is quantified and therefore checkable. The bear view: FY26 adjusted EBITDA guidance flipped from +$1–6M to −$27M/−$23M in one quarter (2026-08-06). Both cases follow in full.

Bull Case

• The guide-down is quantified and therefore checkable. Management sized cyclosporiasis at 200–300bps of FY comparable sales and $7–10M of adjusted EBITDA on the 2026-08-06 call, with a 600–700bps comp drag assumed in Q3 alone. A bar that front-loads the worst quarter can be cleared if traffic normalizes faster than the assumption.
• Cash and equivalents were $142.6M at 2026-06-28, against a guided FY26 adjusted EBITDA loss of $23–27M. On the guide as given, the fiscal year is funded without an equity raise, though capex for roughly 13 net new restaurants is an additional draw.
• Short interest was last reported at 22.889M shares, 24.53% of float, 5.78 days to cover (exchange data reported mid-July 2026). No earnings event exists to force a resolution before ~November, which cuts both ways but leaves the crowded side of the book exposed to drift.
• Digital was 66.3% of Q2 revenue versus 60.8% a year earlier (2026-08-06 release) — channel mix kept shifting while traffic fell.
• Two desks kept constructive targets above the last close: Citi at $8.00 (Buy) and Oppenheimer at $8.50 (Outperform), both set 2026-08-07.
• Unit and menu activity did not stop: the McLean Sweetlane on 2026-08-20 was the fourth drive-thru format location.

Bear Case

• FY26 adjusted EBITDA guidance flipped from +$1–6M to −$27M/−$23M in one quarter (2026-08-06). Profitability is off the table this fiscal year.
• Q2 comps came in at −6.2% against an FY guide of −8.0%/−7.0%, which implies a second half worse than the first.
• Restaurant-level profit margin was 13.1% in Q2 versus 18.9% a year earlier, before the guided step down to 10.5–11.0%. Q2 adjusted EBITDA was $(0.2)M against $6.4M; net loss $(26.3)M against $(23.2)M.
• Six of the eight post-print targets sit below the 2026-08-21 close of $6.99: TD Cowen $5.00 (Hold), DA Davidson $5.50 (Neutral, 2026-08-10), Wells Fargo $6.00 (Equal-Weight), Bank of America $6.40 (cut from $8.00 following the print), UBS $6.50 (Neutral) and RBC $6.50 (Outperform, reiterated 2026-08-11).
• Net new openings guided to about 13 for FY26, with 2 opened in Q2. The revenue line has no unit offset while comps contract.
• Demand weakness is sector-wide, not company-specific: coverage on 2026-08-08 reported salad-chain traffic falling as consumers avoided greens. That removes the "share-shift winner" framing and makes recovery dependent on category behaviour SG does not control.
• Management declined to time the recovery — "the pace and timing of recovery remain uncertain" (2026-08-06 release).

Setup & Price Structure

Reference close 2026-08-21: $6.99. RSI(14) at 63.6 — recovered off the post-print washout, short of an overbought reading. The shares are 31.5% below the 52-week high of $10.21 on the split/dividend-adjusted series, and the three-month price change is −28.5%. Raw trailing-year range reported by stockanalysis.com is $4.49–$10.63.

The structure is a V off a mid-August trough. Quote data for 2026-08-13 showed the shares near $5.82; the 2026-08-14 close was $6.28, and 2026-08-21 closed at $6.99. The single largest day of that leg, 2026-08-21 at +6.23%, carried no company announcement — the last dated item was the prior day's Virginia opening. Overhead, the $7.40 area is the shelf where the July exoneration rally stalled before the print, and it is the first level that would reconnect price to the pre-guide-down structure. Below, the $5.80–$6.00 zone is where the post-print base formed.

Crowding and positioning observables, stated as observables:

• 24.53% of float short as of the mid-July report, 5.78 days to cover. No settlement-date update has been published since the guide-down.
• Price is above six of eight post-print targets, so the analyst community is a source of downgrade risk rather than a marginal bid at this level.
• Daily Political reported on 2026-08-21 that the CFO sold $93,354.93 and the COO $29,863.89 of stock. These are small, likely vest-related dispositions; the observable is that executive selling, not buying, is what printed into the bounce.
• Beta of roughly 2.16 with 62 daily moves greater than 5% in the trailing year on a sub-$1B market cap. Gap risk is a permanent feature.
• No company-scheduled event inside 30 days. The only dated items are short-interest publications.

Catalyst Calendar (next 30 days)

• ~2026-08-26 (est.) — Short interest published for the 2026-08-14 settlement date. First positioning read spanning the 2026-08-06 guide-down.
• ~2026-09-10 (est.) — Short interest for the 2026-08-31 settlement date. Second consecutive datapoint across a window with no company news.
• No company event scheduled inside 30 days. Q3 FY26 results are expected ~2026-11-05 (est.), the quarter management pre-loaded with a 600–700bps outbreak comp drag.
• Ongoing, undated: any CDC or FDA update expanding the Taylor Farms de Mexico traceback would re-open the leafy-green demand overhang across the category.

What Would Change Our Mind

The structure that matters is the base built between 2026-08-13 and 2026-08-14 around $5.80–$6.28. Losing it would say the bounce was mechanical exhaust rather than accumulation, and would put price back at post-outbreak lows with no earnings event to arrest it for roughly ten weeks. Concretely: a weekly close below $6.00 gives back the entire post-guide-down recovery leg.

Two non-price conditions would carry equal weight. First, the ~2026-08-26 and ~2026-09-10 short-interest publications showing the 22.889M-share base materially reduced without price clearing $7.40 — that removes the main mechanical bid and leaves a name whose own guidance calls for an EBITDA loss. Second, the ~2026-11-05 Q3 print landing at or below the guided −8.0% comp assumption with restaurant-level margin under 10.5% would confirm a brand problem rather than a demand shock, and would make a second guide-down the base case rather than a risk.

The reverse — what would restore a narrative leg — is narrower: a weekly close above $7.40 with short interest still above roughly 20% of float, plus a Q3 comp print inside the guided range. Absent both, the case is arithmetic on a reset guide.

Correlation Notes

• Fast-casual comp cycle. CAVA and Chipotle are the read-across names for whether the traffic problem is category-wide or company-specific; a CAVA print preview circulated 2026-08-11. SG's own Q2 comp of −6.2% is not decomposable into outbreak versus brand without a peer baseline.
• Leafy-green supply chain. Taylor Farms de Mexico, the cyclospora source identified in the 2026-07-17 FDA traceback, also supplies McDonald's, Chipotle, Walmart, Target, Costco and Kroger. The demand overhang reported on 2026-08-08 is a category effect, so SG trades with a food-safety headline it did not cause and cannot fix.
• High-short-interest small-cap basket. With beta around 2.16 and a 24.5% short float, day-level moves like 2026-08-21's +6.23% on no company news are more consistent with basket and positioning flow than with name-specific repricing. That inference is not directly observable and would be contradicted if a dated company or analyst item surfaces for that session.
• Consumer discretionary rotation. A sub-$1B restaurant name guiding to an EBITDA loss is a rate- and risk-appetite proxy; the recovery leg since 2026-08-14 coincides with no fundamental change at the company.